Project Grant K24AI187634
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $153,512 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Leland Stanford Junior University. The grant will fund research to characterize the renal immune microenvironment in antibody-mediated rejection (ABMR) of kidney transplants in order to develop improved diagnostics and predict treatment response. The research will utilize advanced imaging mass cytometry to profile...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $147,486 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Johns Hopkins University. The purpose of this 20-month grant, with a period of performance from September 2025 to April 2027, is to identify metabolic targets that could reinvigorate exhausted T cells and enhance their function against viruses, bacteria, and tumors. The research aims to elucidate how chronic T cell...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded Georgetown University a $429,000 Project Grant to conduct research on "Cell-Type-Specific Evaluation of Liver Allografts During Normothermic-Machine-Perfusion." The grant, awarded under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to advance the use of normothermic machine perfusion (NMP) technology and cell-free methylated DNA (cfDNA) monitoring to assess the...
- This federal Project Grant award of $1,031,754.00, awarded on September 2, 2025 by the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research), supports research at The Johns Hopkins University to develop clinically relevant pharmacologic and immunomodulatory strategies to achieve long-term survival of kidney xenografts in primates. The research aims to advance understanding and treatment of infectious diseases and immune system disorders,...
- This $402,731 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), authorized under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund a program to increase the number of next-generation physician-scientists who can apply knowledge of microbiology, immunology, and research techniques to improve reproductive, maternal, and child health. The award will support 4 physician-scientists in pediatrics or obstetrics/gynecology residency...
- This federal Project Grant award of $1,442,898.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to study the effects of vaccination on outcomes of acute and post-acute respiratory viral infections, including COVID-19, in solid organ transplant recipients. The research aims to better understand the risks of severe respiratory viral infections and associated post-acute syndromes...
- This federal Project Grant award, valued at $459,439.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research aimed at improving the understanding of alloreactivity, the immune response that leads to acute cellular rejection of transplanted tissues. The research seeks to identify the specific peptide-HLA complexes recognized by alloreactive T cells, which could...
- This federal Project Grant award, in the amount of $766,265, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to understand the role of regulatory T cells (Tregs) in promoting donor-specific transplantation tolerance, which could improve outcomes for transplant patients by eliminating the need for chronic immunosuppression. Key areas of investigation include...
- This Project Grant award in the amount of $144,486 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The grant supports research at St. Jude Children's Research Hospital Graduate School of Biomedical Sciences, LLC to study metabolic signaling pathways that regulate the functional heterogeneity of regulatory T (Treg) cells. The research aims to uncover how metabolic processes...
- The National Institute of Allergy and Infectious Diseases (NIAID), through the Allergy and Infectious Diseases Research grant program (CFDA 93.855), awarded a $300,000 Project Grant to The Methodist Hospital Research Institute in Houston, TX. The grant project, titled "LDHA-Dependent T-Cell Effector Programs in Heart Transplantation", investigates the role of lactate dehydrogenase A (LDHA) in regulating the differentiation of T-cell effectors, which play a critical role in rejecting...
This federal Project Grant award of $125,596 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports a 5-year research and mentorship program led by Dr. Ali Zarrinpar at the University of Florida. The research aims to integrate methodology from model systems with human samples to learn how to use metabolic modulation to affect the immune response to ischemia-reperfusion injury, a major source of graft injury during organ transplantation. The mentorship component focuses on continued training of students and early-career researchers in patient-oriented research methods, data analysis, grant writing, and professional development within Dr. Zarrinpar's research laboratory and broader university training programs. The award period runs from September 9, 2025 to August 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $125.6k | 9/9/25 |